Huaxia Eye Hospital Group Co., Ltd.

Huaxia Eye Hospital Group Co., Ltd.

SSZSE:301267
14.72
CNY
-0.01
(-0.07%)
0.56EPS
26.88P/E
12.73BMarket Cap
May 04Next Earn

Total Valuation

CNY

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. carries a market capitalization of 12.73B, placing it among publicly traded companies globally. Its enterprise value stands at 9.96B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap12.73B
Enterprise Value9.96B

Important Dates

Huaxia Eye Hospital Group Co., Ltd.'s next confirmed earnings release is scheduled for May 4, 2027.

Earnings Date5/4/2027

Share Statistics

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. has 840.00M shares outstanding.

Shares Outstanding840.00M

Valuation Ratios

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. trades at a trailing price-to-earnings ratio of 26.88. The price-to-sales ratio is 3.02, and the price-to-book ratio stands at 2.28.

PE Ratio26.88
PS Ratio3.02
PB Ratio2.28
P/TBV Ratio2.61

Enterprise Valuation

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. trades at an EV/EBITDA multiple of 15.43 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.37 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 15.43 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 9.96B versus a market cap of 12.73B, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.37
EV / EBITDA15.43
EV / EBIT15.43

Financial Position

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. maintains a current ratio of 3.69, meaning it holds 3.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 18.66, indicating elevated leverage, while an interest coverage ratio of 13.76 demonstrates strong ability to service its debt obligations.

Current Ratio3.69
Quick Ratio3.12
Debt / Equity18.66
Debt / EBITDA1.67
Interest Coverage13.76

Financial Efficiency

CNY

These figures cover the twelve months ended September 30, 2026. The company generates approximately 513,257.87 in revenue per employee across its workforce of 8,200.00, a quick read on workforce productivity versus industry peers.

Revenue Per Employee513,257.87
Employee Count8,200.00

Taxes

CNY

Over the twelve months ended September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. recorded 158.87M in income tax expense. That works out to an effective tax rate of 25.24, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 629.33M, leaving 473.15M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

Income Tax158.87M
Effective Tax Rate25.24

Stock Price Statistics

CNY

As of the close on November 17, 2026, Huaxia Eye Hospital Group Co., Ltd.'s stock has declined approximately 27.88% over the past 52 weeks. The 50-day moving average sits at 14.95, while the 200-day moving average is 16.49.

52-Week Price Change-27.88%
50-Day Moving Average14.95
200-Day Moving Average16.49

Income Statement

CNY

Over the twelve months ended September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. generated 4.21B in revenue and converted that into 473.15M in net income, yielding earnings per share of 0.56. EBITDA reached 645.46M, while operating income came in at 662.83M.

Revenue4.21B
Gross Profit1.81B
Operating Income662.83M
Pretax Income629.33M
Net Income473.15M
EBITDA645.46M
EBIT645.46M
Earnings Per Share (EPS)0.56

Balance Sheet

CNY

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. holds 4.04B in cash and equivalents against 1.08B in total debt, resulting in a net debt position of -534.99M. Total book value stands at 5.59B, with working capital of 3.48B providing operational flexibility.

Cash & Cash Equivalents4.04B
Total Debt1.08B
Net Debt-534.99M
Equity (Book Value)5.59B
Book Value Per Share6.66
Working Capital3.48B

Cash Flow

CNY

These figures cover the twelve months ended September 30, 2026.

Capital Expenditures-202.58M

Margins

Over the twelve months ended September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. posted a gross margin of 43.00, reflecting its pricing power and cost economics. The operating margin of 15.75 and net profit margin of 11.24 provide insight into operational efficiency.

Gross Margin43.00
Operating Margin15.75
Pretax Margin14.95
Profit Margin11.24
EBITDA Margin15.34

Dividends & Yields

CNY

Over the twelve months ended September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. paid dividends of 0.27 per share. The dividend payout ratio of 48.23 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Total shareholder yield reaches 5.42, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Huaxia Eye Hospital Group Co., Ltd. shareholders.

Dividend Per Share0.27
Payout Ratio48.23
Shareholder Yield5.42

Stock Splits

Huaxia Eye Hospital Group Co., Ltd.'s most recent stock split took place on July 11, 2023 with a 2:3 split ratio.

Last Split Date7/11/2023
Split Ratio2:3

Scores

As of September 30, 2026, Huaxia Eye Hospital Group Co., Ltd. has an Altman Z-Score of 5.73, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score5.73